Figure 1.
Flow chart for patient enrolment in EURECA between March 2016 and November 2018, including the final selection for the nested case-control-control study focusing on risk factors for carbapenem-resistant Enterobacterales (CRE) bloodstream infections (BSIs). CSE, carbapenem-susceptible Enterobacterales.